PLSE - Pulse Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5258.88M
Enterprise Value 3205.01M
Trailing P/E N/A
Forward P/E 1-5.95
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.38
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-5.35

Trading Information

Stock Price History

Beta (3Y Monthly) 1.80
52-Week Change 3-14.22%
S&P500 52-Week Change 37.71%
52 Week High 319.77
52 Week Low 38.60
50-Day Moving Average 312.35
200-Day Moving Average 314.47

Share Statistics

Avg Vol (3 month) 354.53k
Avg Vol (10 day) 339.62k
Shares Outstanding 520.71M
Float 9.07M
% Held by Insiders 159.60%
% Held by Institutions 18.62%
Shares Short (Jun 28, 2019) 42.29M
Short Ratio (Jun 28, 2019) 454.31
Short % of Float (Jun 28, 2019) 420.54%
Short % of Shares Outstanding (Jun 28, 2019) 411.05%
Shares Short (prior month May 31, 2019) 42.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-45.78%
Return on Equity (ttm)-77.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -38.33M
Net Income Avi to Common (ttm)-38.95M
Diluted EPS (ttm)-2.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.8M
Total Cash Per Share (mrq)2.55
Total Debt (mrq)1.62M
Total Debt/Equity (mrq)2.74
Current Ratio (mrq)17.13
Book Value Per Share (mrq)2.85

Cash Flow Statement

Operating Cash Flow (ttm)-26.21M
Levered Free Cash Flow (ttm)-12.12M